Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas C Wolf

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 16, 2002
The carcinogenic response of Tsc2 mutant Long-Evans (Eker) rats to a mixture of drinking water disinfection by-products was less than additiveMichelle J Hooth, Kevin S McDorman, Susan D Hester, et al.
Cancer Letters|October 3, 2002
Mutations in the VHL gene from potassium bromate-induced rat clear cell renal tumorsYih-Horng Shiao, Sonie I Kamata, Leeanne M Li, et al.
Toxicologic Pathology|April 24, 2009
Dimethylarsinic acid in drinking water changed the morphology of urinary bladder but not the expression of DNA repair genes of bladder transitional epithelium in F344 ratsAmy Wang, Douglas C Wolf, Banalata Sen, et al.
Inflammatory Bowel Diseases|October 14, 2020
Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical PracticeNiels Vande Casteele, Brian G Feagan, Douglas C Wolf, et al.
Toxicology Letters|December 18, 2004
Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liverGuobin Sun, Sheau-Fung Thai, Douglas B Tully, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2020
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint studyBrian G Feagan, William J Sandborn, Silvio Danese, et al.
Toxicologic Pathology|July 30, 2009
Potential for a global historical control database for proliferative rodent lesionsCharlotte Keenan, Susan Elmore, Sabine Francke-Carroll, et al.
Gut|July 5, 2012
A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's diseaseBruce E Sands, Seymour Katz, Douglas C Wolf, et al.
Crohn'S & Colitis 360|August 28, 2023
Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE StudiesWilliam J Sandborn, Jingjing Chen, Krisztina Kisfalvi, et al.
Toxicology|August 26, 2014
Dose and temporal effects on gene expression profiles of urothelial cells from rats exposed to diuronShadia M Ihlaseh-Catalano, Kathryn A Bailey, Ana Paula F Cardoso, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 16, 2002
The carcinogenic response of Tsc2 mutant Long-Evans (Eker) rats to a mixture of drinking water disinfection by-products was less than additiveMichelle J Hooth, Kevin S McDorman, Susan D Hester, et al.
Cancer Letters|October 3, 2002
Mutations in the VHL gene from potassium bromate-induced rat clear cell renal tumorsYih-Horng Shiao, Sonie I Kamata, Leeanne M Li, et al.
Toxicologic Pathology|April 24, 2009
Dimethylarsinic acid in drinking water changed the morphology of urinary bladder but not the expression of DNA repair genes of bladder transitional epithelium in F344 ratsAmy Wang, Douglas C Wolf, Banalata Sen, et al.
Inflammatory Bowel Diseases|October 14, 2020
Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical PracticeNiels Vande Casteele, Brian G Feagan, Douglas C Wolf, et al.
Toxicology Letters|December 18, 2004
Propiconazole-induced cytochrome P450 gene expression and enzymatic activities in rat and mouse liverGuobin Sun, Sheau-Fung Thai, Douglas B Tully, et al.
The Lancet. Gastroenterology & Hepatology|June 20, 2020
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint studyBrian G Feagan, William J Sandborn, Silvio Danese, et al.
Toxicologic Pathology|July 30, 2009
Potential for a global historical control database for proliferative rodent lesionsCharlotte Keenan, Susan Elmore, Sabine Francke-Carroll, et al.
Gut|July 5, 2012
A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's diseaseBruce E Sands, Seymour Katz, Douglas C Wolf, et al.
Crohn'S & Colitis 360|August 28, 2023
Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn's Disease: Post Hoc Analyses of VISIBLE StudiesWilliam J Sandborn, Jingjing Chen, Krisztina Kisfalvi, et al.
Toxicology|August 26, 2014
Dose and temporal effects on gene expression profiles of urothelial cells from rats exposed to diuronShadia M Ihlaseh-Catalano, Kathryn A Bailey, Ana Paula F Cardoso, et al.
Pageof 13